What is the current Price Target for the Anavex Life Sciences Corp. stock?

The average Anavex Life Sciences Corp. target price is $44.88. This is 506.49% higher than the current stock price. The highest price target is 552.70%, the lowest is 473.24%. 4 Analysts have issued a price target Anavex Life Sciences Corp. 2026 .

How high will the Anavex Life Sciences Corp. stock rise?

No reliable answer can be given as to how high the Anavex Life Sciences Corp. stock will rise. The performance of stocks, including the Anavex Life Sciences Corp. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Anavex Life Sciences Corp. stock today?

The performance of Anavex Life Sciences Corp. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Anavex Life Sciences Corp. stock fall?

The decline in Anavex Life Sciences Corp. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Anavex Life Sciences Corp. Forecast, price target & analysts

$7.40

1.23% yesterday

Nasdaq, Nov 06, 10:02 pm CET

ISIN

US0327973006

Symbol

AVXL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Anavex Life Sciences Corp. Target price 2025 - Analyst rating & recommendation

Anavex Life Sciences Corp. Classifications & Recommendation:

Buy

78%

Hold

22%

Anavex Life Sciences Corp. Price Target

Target Price	$44.88
Price	$7.40
Potential	506.49% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Anavex Life Sciences Corp. 2026 . The average Anavex Life Sciences Corp. target price is $44.88. This is 506.49% register free of charge higher than the current stock price. The highest price target is $48.30 552.70% register free of charge , the lowest is $42.42 473.24% register free of charge .
	A rating was issued by 9 analysts: 7 Analysts recommend Anavex Life Sciences Corp. to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Anavex Life Sciences Corp. stock has an average upside potential 2026 of 506.49% register free of charge . Most analysts recommend the Anavex Life Sciences Corp. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Sep '24	2025 Estimates
Earnings Per Share $	-0.52	-0.59
	13.33%	13.46%
P/E		negative

5 Analysts have issued a Anavex Life Sciences Corp. forecast for earnings per share. The average Anavex Life Sciences Corp. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.52	13.33%
2025	$-0.59 13.46% Unlock
2026	$1.44 344.07% Unlock
2027	$3.82 165.28% Unlock
2028	$11.20 193.19% Unlock
2029	$13.65 21.88% Unlock
2030	$15.05 10.26% Unlock
2031	$22.34 48.44% Unlock
2032	$28.47 27.44% Unlock

Current	-12.98	3.13%
2025	-12.58 3.10% Unlock
2026	5.15 140.94% Unlock
2027	1.94 62.33% Unlock
2028	0.66 65.98% Unlock
2029	0.54 18.18% Unlock
2030	0.49 9.26% Unlock
2031	0.33 32.65% Unlock
2032	0.26 21.21% Unlock

Anavex Life Sciences Corp....

Current Anavex Life Sciences Corp. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
D. Boral Capital	Locked ➜ Locked	Locked	Oct 29 2025
Jones Trading	Locked ➜ Locked	Locked	Oct 24 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 07 2025
D. Boral Capital	Locked ➜ Locked	Locked	Oct 02 2025
D. Boral Capital	Locked ➜ Locked	Locked	Oct 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 10 2025
D. Boral Capital	Locked ➜ Locked	Locked	Sep 10 2025

Analyst Rating	Date
Locked D. Boral Capital: Locked ➜ Locked	Oct 29 2025
Locked Jones Trading: Locked ➜ Locked	Oct 24 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 07 2025
Locked D. Boral Capital: Locked ➜ Locked	Oct 02 2025
Locked D. Boral Capital: Locked ➜ Locked	Oct 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 10 2025
Locked D. Boral Capital: Locked ➜ Locked	Sep 10 2025

Discover more stocks with a high price target

TUI 61.53%

Novo Nordisk 52.03%

Adidas 51.38%

Deutsche Telekom 47.10%

Meta Platforms (Facebook) 44.20%

Coinbase Global, Inc. 39.58%

BYD 38.89%

Adyen 36.70%

BioNTech SE - ADR 34.72%

Rheinmetall 31.38%

Microsoft 29.27%

Netflix 29.24%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now